144
Views
22
CrossRef citations to date
0
Altmetric
Research Article

Proteomic analysis of differential protein expression in atherosclerosis

, , , , &
Pages 279-290 | Received 21 Oct 2004, Published online: 08 Oct 2008

References

  • Abrams J. C-reactive protein, inflammation, and coronary risk: an update. Cardiology Clinics 2003; 21: 327–331
  • Andersen PS, Havndrup O, Bundgaard H, Moolman-Smook JC, Larsen LA, Mogensen J, Brink PA, Borglum AD, Corfield VA, Kjeldsen K, et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. Journal of Medical Genetics 2001; 38: E43
  • Andersson M, Sjostrand J, Karlsson JO. Calpains in the human lens: relations to membranes and possible role in cataract formation. Ophthalmic Research 1996; 28: 51–54
  • Andersson M, Sjostrand J, Petersen A, Karlsson JO. Calcium-dependent proteolysis in rabbit lens epithelium after oxidative stress. Ophthalmic Research 1998; 30: 157–167
  • Antovani A, Locati M, Vecchi A, Sozzani S, Allavena P. Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines. Trends in Immunology 2001; 22: 328–336
  • Ashkenazi A, Dixit VM. Apoptosis control by death and decoy receptors. Current Opinions in Cell Biology 1999; 11: 255–260
  • Autieri MV, Carbone CJ. 14-3-3Gamma interacts with and is phosphorylated by multiple protein kinase C isoforms in PDGF-stimulated human vascular smooth muscle cells. DNA and Cell Biology 1999; 18: 555–564
  • Autieri MV, Haines DS, Romanic AM, Ohlstein EH. Expression of 14-3-3 gamma in injured arteries and growth factor- and cytokine-stimulated human vascular smooth muscle cells. Cell Growth and Differentiation 1996; 7: 1453–1460
  • Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease. European Heart Journal 2003; 24: 2166–2179
  • Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Journal of the American Medical Association 1998; 279: 1477–1482
  • Danuta SC, Georgianna G, Shin NS, Jiaju Z. Familial hypertrophic cardiomyopathy-linked alterations in Ca2-binding of human cardiac myosin regulatory light chain affect cardiac muscle contraction. Journal of Biological Chemistry 2004; 279: 3535–3542
  • Doherty TM, Fitzpatrick LA, Shaheen A, Rajavashisth TB, Detrano RC. Genetic determinants of arterial calcification associated with atherosclerosis. Mayo Clinic Proceedings 2004; 79: 197–210
  • Elgharib N, Chi DS, Younis W, Wehbe S, Krishnaswamy G. C-reactive protein as a novel biomarker: Reactant can flag atherosclerosis and help predict cardiac events. Postgraduate Medicine 2003; 114: 39–44
  • Fassbender K, Bertsch T, Mielke O, Mühlhauser F, Hennerici M. Adhesion molecules in cerebrovascular diseases. Evidence for an inflammatory endothelial activation in cerebral large- and small-vessel disease. Stroke 1999; 30: 1647–1650
  • Flavigny J, Richard P, Isnard R, Carrier L, Charron P, Bonne G, Forissier JF, Desnos M, Dubourg O, Komajda M, et al. Identification of two novel mutations in the ventricular regulatory myosin light chain gene (MYL2) associated with familial and classical forms of hypertrophic cardiomyopathy. Journal of Molecular Medicine 1998; 76: 208–214
  • Fyfe AI, Rothenberg LS, DeBeer FC, Cantor RM, Rotter JI, Lusis AJ. Association between serum amyloid a proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997; 96: 2914–2919
  • Gao WD, Liu Y, Mellgren R, Marban E. Intrinsic myofilament alterations underlying the decreased contractility of stunned myocardium. A consequence of Ca2 + -dependent proteolysis?. Circulation Research 1996; 78: 455–465
  • Gevaert K, Vandekerchhove J. Protein identification methods in proteomics. Electrophoresis 2000; 21: 1145–1154
  • Jalkanen J, Leppanen P, Narvanen O, Greaves DR, Yla-Herttuala S. Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice. Atherosclerosis 2003; 169: 95–103
  • Marcus CS, Martin AH, Richard AZ, Ingo M. Modulation of contractility in human cardiac hypertrophy by myosin essential light chain isoforms. Cardiovascular Research 1998; 37: 381–404
  • Morgan A, Burgoyne RD. Exol and Exo2 proteins stimulate calcium-dependent exocytosis in permeabilized adrenal chromaff in cells. Nature 1992; 355: 833–836
  • Nomoto K, Oguchi S, Watanabe I, Kushiro T, Kanmatsuse K. Involvement of inflammation in acute coronary syndromes assessed by levels of high-sensitivity C-reactive protein, matrix metalloproteinase-9 and soluble vascular-cell adhesion molecule-1. Journal of Cardiology 2003; 42: 201–206
  • Papp Z, Van der Velden J, Stienen GJ. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart. Cardiovascular Research 2000; 45: 981–993
  • Poetter K, Jiang H, Hassanzadeh S, Master SR, Chang A, Dalakas MC, Rayment I, Sellers JR, Fananapazir L, Epstein ND. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle. Nature Genetics 1996; 13: 63–69
  • Ramachandran C, Kennedy BP. Protein tyrosine phosphatase 1B: a novel target for type 2 diabetes and obesity. Current Topics in Medical Chemistry 2003; 3: 749–757
  • Reape TJ, Groot PH. Chemokines and atherosclerosis. Atherosclerosis 1999; 147: 213–225
  • Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993; 341: 1165–1168
  • Ross R. Atherosclerosis — an inflammatory disease. New England Journal of Medicine 1999; 340: 115–126
  • Sato Y. Aminopeptidases and angiogenesis. Endothelium 2003; 10: 287–290
  • Sorimachi H, Ishiura S, Suzuki K. Structure and physiological function of calpains. Biochemical Journal 1997; 328: 721–732
  • Tjoelker LW, Stafforini DM. Platelet-activating factor acetylhydrolases in health and disease. Biochimica et Biophysica Acta 2000; 31: 102–123
  • Tousoulis D, Davies G, Stefanadis C, Toutouzas P, Ambrose JA. Inflammatory and thrombotic mechanisms in coronary atherosclerosis. Heart 2003; 89: 993–997
  • Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T. The role of protein-tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 2000; 149: 51–59
  • Vorchheimer DA, Fuster V. Inflammatory markers in coronary artery disease: let prevention douse the flames. Journal of the American Medical Association 2001; 286: 2154–2156
  • Wang J, Sheppard GS, Lou P, Kawai M, BaMaung N, Erickson SA, Tucker-Garcia L, Park C, Bouska J, Wang YC, et al. Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2. Cancer Research 2003; 63: 7861–7869
  • Wheeler-Jones CPD, Learmonth MP, Martin H, Aitken A. Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation. Biochemical Journal 1996; 315: 41–47
  • Yoshida K, Yamasaki Y, Kawashima S. Calpain activity alters in rat myocardial subfractions after ischemia and reperfusion. Biochimica et Biophysica Acta 1995; 1182: 215–220

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.